Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereotactic body radiation therapy (SBRT). However, few guidelines exist. We summarize the results of an international survey reviewing technical factors for extracranial SBRT for oligometastatic disease to guide safe management. Materials & methods: Seven highvolume centers contributed. Levels of agreement were categorized as strong (6-7 common responses), moderate (4-5), low (2-3) or no agreement. Results & conclusion: We present the results of a multi-national and multi-institutional survey of technical factors of SBRT for extracranial oligometastases. Key methods including target delineation, prescription doses, normal tissue constraints, imag...
Oligometastases from solid tumors are currently recognized as a distinct clinical entity, correspond...
Oligometastatic disease is defined as “a condition with a few metastases arising from tumors t...
International audienceThe role of radiation therapy in metastatic disease has evolved from palliativ...
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereo...
Aims Stereotactic body radiotherapy (SBRT) for oligometastases is increasingly used with few evidenc...
AbstractIn patients with proven distant metastases from solid tumors, it has been a notion that the ...
In patients with proven distant metastases from solid tumors, it has been a notion that the conditio...
Stereotactic body radiation therapy (SBRT) is a form of radiation therapy (RT) in which a small numb...
Selection of patients with extracranial oligometastatic disease who may benefit from metastasis-dire...
In the last years, several evidences demonstrated the role of stereotactic body radiotherapy (SBRT) ...
Aims: To retrospectively review the toxicity and early outcome data from patients who have received ...
Objectives: To review the available data about stereotactic body-radiotherapy (SBRT) for oligometast...
PURPOSE: Fewer attendances for radiation therapy results in increased efficiency and less foot traff...
AIM: To provide a multi-institutional description of current practices of stereotactic body radiothe...
International audienceABSTRACT: Advances in imaging and biological targeting have led to the develop...
Oligometastases from solid tumors are currently recognized as a distinct clinical entity, correspond...
Oligometastatic disease is defined as “a condition with a few metastases arising from tumors t...
International audienceThe role of radiation therapy in metastatic disease has evolved from palliativ...
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereo...
Aims Stereotactic body radiotherapy (SBRT) for oligometastases is increasingly used with few evidenc...
AbstractIn patients with proven distant metastases from solid tumors, it has been a notion that the ...
In patients with proven distant metastases from solid tumors, it has been a notion that the conditio...
Stereotactic body radiation therapy (SBRT) is a form of radiation therapy (RT) in which a small numb...
Selection of patients with extracranial oligometastatic disease who may benefit from metastasis-dire...
In the last years, several evidences demonstrated the role of stereotactic body radiotherapy (SBRT) ...
Aims: To retrospectively review the toxicity and early outcome data from patients who have received ...
Objectives: To review the available data about stereotactic body-radiotherapy (SBRT) for oligometast...
PURPOSE: Fewer attendances for radiation therapy results in increased efficiency and less foot traff...
AIM: To provide a multi-institutional description of current practices of stereotactic body radiothe...
International audienceABSTRACT: Advances in imaging and biological targeting have led to the develop...
Oligometastases from solid tumors are currently recognized as a distinct clinical entity, correspond...
Oligometastatic disease is defined as “a condition with a few metastases arising from tumors t...
International audienceThe role of radiation therapy in metastatic disease has evolved from palliativ...